Label Changes for:

Savella (Milnacipran HCL) Tablets

December 2012

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – February 2010, October and December 2012

 

December 2012

 

ADVERSE REACTIONS

Postmarketing Spontaneous Reports
Psychiatric Disorders
Advertisement
Close

Recommended

(web6)